06 Jun 2021 / 07:14 H.
KUALA LUMPUR: The Ministry of Health (MOH) and the Institute for Clinical Research (ICR) have started clinical trials to study the use and efficacy of Ivermectin for high-risk Covid-19 patients at 12 MOH’s hospitals.
Health director-general Tan Sri Dr Noor Hisham Abdullah
(pix) said Ivermectin is a Food and Drug Administration (FDA) approved antiparasitic drug widely used for treating several neglected tropical diseases, including onchocerciasis, strongyloidiasis and helminthiases, however, the evidence is inconclusive to recommend routine use of Ivermectin for Covid-19 patients.
“The ‘off-label’ use of Ivermectin gained global attention due to some promising results by case studies and clinical trials.
PETALING JAYA: Three thousand Malaysian adults will be invited to participate in the phase three clinical trials for a new vaccine manufactured by Chinese firm Shenzhen Kangtai Biological Products Co Ltd, says the Health Ministry.
Health director-general Tan Sri Dr Noor Hisham Abdullah said the clinical study involving the inactivated vaccine was approved by the National Pharmaceutical Regulatory Division (NPRA) on May 28.
The third phase of the clinical study of this vaccine would be conducted in eight research centres in Malaysia targeting the participation of 3,000 adults aged 18 and above and was expected to take 15 to 19 months, he said.
“The Health Ministry would like to inform that there is an addition of one clinical study, involving the product SARS-CoV-2 Vaccine (Vero Cells), Inactivated, 5μg/0.5mL manufactured by Shenzhen Kangtai Biological Products Co Ltd from China.
KUALA LUMPUR, June 6 (Bernama): The FTSE Bursa Malaysia (FBM KLCI) is expected to trade sideways this week with the level of resistance located at 1,600 to 1610 points.
Market players will be monitoring the country’s April industrial production index to be released by the Statistics Department and the European Central Bank’s (ECB) policy rate meeting.
Bank Islam Malaysia Bhd economist Adam Mohamed Rahim said the holiday-shortened week would contribute further to the market lull as there seemed to be no new fresh catalyst in the market.
The local bourse will be closed on Monday, June 7, in conjunction with the official birthday of the Yang di-Pertuan Agong Al-Sultan Abdullah Ri’ayatuddin Al-Mustafa Billah Shah. The local bourse and its subsidiaries will resume operations on Tuesday, June 8.